PT-141 – 10mg (Lyophilised)
Product & Research Profile
PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide analogue derived from the melanocortin peptide family and structurally related to alpha-melanocyte-stimulating hormone (α-MSH).
Its cyclic peptide structure and modified amino-acid sequence give PT-141 a distinct receptor-binding profile, with laboratory research focused particularly on melanocortin receptors including MC3R and MC4R.
This makes PT-141 of interest in controlled research involving melanocortin receptor pharmacology, peptide–receptor interactions, cyclic peptide structure–activity relationships, receptor-mediated signalling and comparative analysis with other melanocortin analogues.
Its defined seven-amino-acid framework also makes it suitable for analytical characterisation, ligand-binding studies and reference comparison within melanocortin-related research.
Supplied as a lyophilised powder in sealed laboratory vials, PT-141 is available in a 10mg quantity for research and analytical applications.
18+ Purchase Confirmation
By placing an order, you confirm that you are 18 years of age or older and are purchasing on behalf of a laboratory, organisation, or professional research activity.
Product Details
Product Form: Lyophilised powder
Purity: ≥98%
Quantity: 10mg
Packaging: Sterile sealed vial
Legal Use
This product is sold strictly for in-vitro research and laboratory use only. It is not a medicine, supplement, or cosmetic and must not be consumed, injected, or applied to humans or animals.
Suitable for analytical testing, reference comparison and controlled peptide research.
Storage, Handling & Safety
Store frozen at −20 °C for long-term stability. Short-term temperature fluctuations during shipping do not affect product integrity.
Protect from heat, moisture, and direct light.
Products may present chemical hazards. Appropriate laboratory PPE, engineering controls, and disposal procedures must be followed at all times.
For laboratory research use only. Not for human or veterinary use.